Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1993-04-06
1994-11-22
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
435219, 424 941, A61K 37547, A61K 37553, A61K 3748, C12N 950
Patent
active
053667301
ABSTRACT:
Pharmaceutical preparation of a protein with t-PA activity with an enzymatic activity of at least 0.25 MU/ml. and a pH value of 4.5 to 9 which contains a substance of the group citric acid, ascorbic acid, 2-oxoglutaric acid, fumaric acid, Tris and EDTA in a concentration of at least 0.2 mole/l., as well as a medicament based on a protein with t-PA activity and processes for its preparation.
REFERENCES:
patent: 4568544 (1986-02-01), Hasegawa et al.
patent: 4898826 (1990-02-01), Duffy et al.
patent: 4980165 (1990-12-01), Isaacs et al.
patent: 5068106 (1991-11-01), Paques et al.
patent: 5095034 (1992-03-01), Kato et al.
Methods of Enzymology--vol. 182, 1990 Academic Press Inc. Deutscher, Murray P., Guide to Protein Purification, Chap. 8, "Maintaining Protein Stability", pp. 83-86.
Ranby et al., "Blood Collection in Strong Acidic Citrate anticoagulant used in a study of dietary influence on Basal & Pa Activity" Thrombosis and Haemostasis, 62(3), pp. 917-922 (1989).
Kohnert Ulrich
Rudolph Rainer
Boehringer Mannheim GmbH
Larson Kristin
Robinson Douglas W.
LandOfFree
Stabilized compositions having human tissue type plasminogen act does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized compositions having human tissue type plasminogen act, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized compositions having human tissue type plasminogen act will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1989805